Atlas Trials

Sorafenib/Docetaxel Dose Escalation Trial

Clinical trial NCT00562523 · COMPLETED

Trial details

NCT number
NCT00562523
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2007-11-01
Primary completion
2009-03-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.